Text with patent numbers: |
|
||||||||||||||||||||||||
Title: | |||||||||||||||||||||||||
Abstract: | |||||||||||||||||||||||||
Specification: | |||||||||||||||||||||||||
Claims: | |||||||||||||||||||||||||
Inventor: | |||||||||||||||||||||||||
Assg. orig: | |||||||||||||||||||||||||
Assg. curr: | |||||||||||||||||||||||||
Expiry from: | to: | ||||||||||||||||||||||||
Priority from:sa | to: | ||||||||||||||||||||||||
Ref. by: | and more | Ind.cl: | and shorter | ||||||||||||||||||||||
Entity: | Type: | Expired: | Maint.status: | ||||||||||||||||||||||
Score from: | % to: % | Current assig. owns from to patents |
patent | score | priority | expiry | expired | references | current assignee | title |
---|---|---|---|---|---|---|---|
8486696 | 23 | 2001-09-21 | 2028-03-27 | 0 | 7 | GARNET BIOTHERAPEUTICS, INC ; | Cell populations which co-express CD49c and CD90 |
9969980 | 64 | 2001-09-21 | 2028-10-11 | 0 | 0 | GARNET BIOTHERAPEUTICS, INC ; | Cell populations which co-express CD49c and CD90 |
9969977 | 70 | 2002-09-20 | 2034-01-19 | 0 | 0 | GARNET BIOTHERAPEUTICS, INC ; | Cell populations which co-express CD49c and CD90 |
10351826 | 89 | 2001-09-21 | 2024-04-05 | 1 | 0 | GARNET BIOTHERAPEUTICS, INC ; | Cell populations which co-express CD49c and CD90 |